LAM is caused by inactivating mutations in tumor suppressor genes tuberous sclerosis complex 1 and 2 (TSC1 / TSC2) that negatively regulate cell growth through inhibition of a signaling protein complex called mechanistic target of rapamycin (mTOR). Here, TSC2 is linked to lymphangioleiomyomatosis.